AstraZeneca PLC (AZN)

33.30
0.25 0.76
NYSE : Health Care
Prev Close 33.05
Open 33.11
Day Low/High 33.05 / 33.42
52 Wk Low/High 26.97 / 35.04
Volume 2.48M
Avg Volume 6.19M
Exchange NYSE
Shares Outstanding 2.53B
Market Cap 84.07B
EPS 1.10
P/E Ratio 14.90
Div & Yield 0.90 (2.70%)

Latest News

Stocks Extend Decline as Crude Falls to One-Week Low

Stocks Extend Decline as Crude Falls to One-Week Low

Stocks hold slightly lower by mid-afternoon Wednesday as a greater build to inventories accelerates losses in crude oil.

European Markets Mixed as Volatility Hits 17-Month Low

European Markets Mixed as Volatility Hits 17-Month Low

Mining stocks pull down London's benchmark index.

Stocks Hold Losses as Crude Oil Extends Decline

Stocks Hold Losses as Crude Oil Extends Decline

Stocks hold slightly lower by mid-afternoon Wednesday as a greater build to inventories accelerates losses in crude oil.

Pfizer Is Buying a Portion of AstraZeneca's Antibiotics Business

Pfizer Is Buying a Portion of AstraZeneca's Antibiotics Business

Pfizer is making another acquisition.

Stock Futures Little Changed in Wait for Friday's Yellen Speech

Stock Futures Little Changed in Wait for Friday's Yellen Speech

Stock futures remain close to the flatline on Wednesday as investors await a critical speech from Federal Reserve Chair Janet Yellen at the end of the week.

Pfizer Picks Up AstraZeneca's Antibiotics Business

Pfizer Picks Up AstraZeneca's Antibiotics Business

The deal could be worth $1.5 billion.

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

Pfizer buys antibiotics business from AstraZeneca; Tesla unveils Model S version that can go 300 miles on a single charge; U.S. stock futures rise slightly.

European Markets Steady; Italy Hit by Earthquake

European Markets Steady; Italy Hit by Earthquake

Central part of Italy hit by 6.2 magnitude earthquake.

Medivation Scores Premium in Sale to Pfizer

Medivation Scores Premium in Sale to Pfizer

Shareholders of the oncology drug maker ought to be satisfied with the auction's conclusion.

Crude Selloff, Health Care Rally Split Wall Street

Crude Selloff, Health Care Rally Split Wall Street

Stocks fluctuate on Monday as doubts over a production freeze agreement from major oil-producing countries snapped crude oil's recent rally.

Pfizer Confirms $14 Billion Takeover of Cancer Drugmaker Medivation

Pfizer Confirms $14 Billion Takeover of Cancer Drugmaker Medivation

Acquiring Medivation will strengthen Pfizer's oncology franchise, which has lost ground in recent years to some Big Pharma competitors.

4 Stocks to Avoid Amid the Mad 'Search for Yield'

4 Stocks to Avoid Amid the Mad 'Search for Yield'

There's a price to pay for low expectations.

Why AstraZeneca (AZN) Stock Is Higher Today

Why AstraZeneca (AZN) Stock Is Higher Today

On Friday, AstraZeneca (AZN) stock hit the price offered by Pfizer (PFE) in 2014, helped in part by Bristol-Myers' (BMY) failed lung cancer study.

AstraZeneca (AZN) Leads The Pack In Pre-Market Activity

AstraZeneca (AZN) Leads The Pack In Pre-Market Activity

Trade-Ideas LLC identified AstraZeneca (AZN) as a pre-market leader candidate

Pfizer Beats Estimates for Second-Quarter Revenue, Earnings per Share

Pfizer Beats Estimates for Second-Quarter Revenue, Earnings per Share

The world's largest pharma company, Pfizer, tops expectations and reaffirms guidance for the full year.

3 Stocks Underperforming Today In The Drugs Industry

3 Stocks Underperforming Today In The Drugs Industry

TheStreet highlights 3 stocks pushing the drugs industry lower today.

Closing Bell: Tinder Boosts Match; Earnings Drive S&P 500 Higher

Closing Bell: Tinder Boosts Match; Earnings Drive S&P 500 Higher

Another busy day on the earnings calendar kept trading erratic again on Thursday, though the S&P 500 and Nasdaq managed to clinch slight gains by the end of the session.

AstraZeneca (AZN) Stock Up After Q2 Earnings, Revenue Beat

AstraZeneca (AZN) Stock Up After Q2 Earnings, Revenue Beat

AstraZeneca (AZN) stock is increasing this afternoon after the company reported better-than-expected results before today's market open.

Hep C Business Slow-Down Could Hamper Bristol-Myers' Future

Hep C Business Slow-Down Could Hamper Bristol-Myers' Future

The company's hepatitis C drug division is expected to see losses in the second half of the year.

AstraZeneca (AZN) Leading In Pre-Market Activity

AstraZeneca (AZN) Leading In Pre-Market Activity

Trade-Ideas LLC identified AstraZeneca (AZN) as a pre-market leader candidate

AstraZeneca Earnings, Sales Edge Above Forecasts

AstraZeneca Earnings, Sales Edge Above Forecasts

CEO Soriot says the company's pipeline is progressing well, and predicts a boost to full-year earnings from a decline in the pound.

3 Stocks Boosting The Health Care Sector Higher

3 Stocks Boosting The Health Care Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.

Analysts' Actions -- GE, Nordstrom, Rockwell Collins, Sprint and More

Analysts' Actions -- GE, Nordstrom, Rockwell Collins, Sprint and More

Here are Tuesday's top research calls, including upgrades for GE, Nordstrom and Sprint, and a downgrade for Rockwell Collins.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AZN, BOOT, CFCB, CMFN, CSS, GE, KFS, NBHC, OMN, OSB, PCH, SBFG, UNFI Downgrades: ATAI, FCCY Initiations: CNV Read on to get TheStreet Quant Ratings' detailed report:

Global Week Ahead: Report Card Time for European Banks, BOJ Monetary Policy Meeting

Global Week Ahead: Report Card Time for European Banks, BOJ Monetary Policy Meeting

Expect a barrage of key indicators and earnings from companies including Deutsche Bank, LVMH, Diageo and AB InBev.

European Stock Markets Mixed After Signs of Brexit Damage

European Stock Markets Mixed After Signs of Brexit Damage

Purchasing managers' surveys point toward a slowdown in U.K services and manufacturing

Clouds With a Golden Lining: Enterprise Software Targets

Clouds With a Golden Lining: Enterprise Software Targets

As large tech groups and private sponsors shop for software companies, outfits with enterprise clients and cloud services have come into focus.

Relypsa Finally Finds Buyer, but Potential Seen For Rival Bid

Relypsa Finally Finds Buyer, but Potential Seen For Rival Bid

Shares of Relypsa are rallying after the company announced it has agreed to be acquired by Galenica Group in a $1.53B deal.